(Q1 Un-audited): Consolidated EPS was Tk. 1.86 for July-September, 2018 as against Tk. 1.59 for July-September, 2017; Consolidated NOCFPS was Tk. 1.05 for July-September, 2018 as against Tk. 1.56 for July-September, 2017. Consolidated NAV per share was Tk. 68.59 as on September 30, 2018 and Tk. 63.36 as on September 30, 2017. As the company acquired Nuvista Pharma on 2.4.18, the comparative prior period figures are reported in the consolidated figures.